573 related articles for article (PubMed ID: 29956726)
1. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
3. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial-mesenchymal transition.
Zhang C; Xu Y; Wang H; Li G; Yan H; Fei Z; Xu Y; Li W
Anticancer Drugs; 2018 Apr; 29(4):334-340. PubMed ID: 29420338
[TBL] [Abstract][Full Text] [Related]
4. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.
Shakibaei M; Buhrmann C; Kraehe P; Shayan P; Lueders C; Goel A
PLoS One; 2014; 9(1):e85397. PubMed ID: 24404205
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.
Sun X; Martin RCG; Zheng Q; Farmer R; Pandit H; Li X; Jacob K; Suo J; Li Y
Cell Oncol (Dordr); 2018 Dec; 41(6):651-662. PubMed ID: 30116994
[TBL] [Abstract][Full Text] [Related]
7. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gαi-2 and Gαq/11.
Chen MC; Baskaran R; Lee NH; Hsu HH; Ho TJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
J Cell Physiol; 2019 Jul; 234(7):11822-11834. PubMed ID: 30552676
[TBL] [Abstract][Full Text] [Related]
8. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
10. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
[TBL] [Abstract][Full Text] [Related]
11. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
Kim D; Park M; Jang H; Hyun H; Lim W
Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
[TBL] [Abstract][Full Text] [Related]
12. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
13. Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z; Gabrisova V; Kucerova L
Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
15. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
17. Sphere formation assay is not an effective method for cancer stem cell derivation and characterization from the Caco-2 colorectal cell line.
Wu H; Zhang H; Hu Y; Xia Q; Liu C; Li Y; Yu B; Gu T; Zhang X; Yu X; Kong W
Curr Stem Cell Res Ther; 2014 Mar; 9(2):82-8. PubMed ID: 24359140
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
19. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
20. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo.
Jeng LB; Kumar Velmurugan B; Chen MC; Hsu HH; Ho TJ; Day CH; Lin YM; Padma VV; Tu CC; Huang CY
J Cell Physiol; 2018 Sep; 233(9):7134-7142. PubMed ID: 29574877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
